Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells.
Ontology highlight
ABSTRACT: DNA repair promotes the progression and recurrence of glioblastoma (GBM). However, there remain no effective therapies for targeting the DNA damage response and repair (DDR) pathway in the clinical setting. Thus, we aimed to conduct a comprehensive analysis of DDR genes in GBM specimens to understand the molecular mechanisms underlying treatment resistance. Herein, transcriptomic analysis of 177 well-defined DDR genes was performed with normal and GBM specimens (n = 137) from The Cancer Genome Atlas and further integrated with the expression profiling of histone deacetylase 6 (HDAC6) inhibition in temozolomide (TMZ)-resistant GBM cells and patient-derived tumor cells. The effects of HDAC6 inhibition on DDR signaling were examined both in vitro and intracranial mouse models. We found that t
SUBMITTER: Yang WB
PROVIDER: S-EPMC8479077 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA